Historique de carrière de Shirish Dabir
Anciens postes connus de Shirish Dabir
Sociétés | Poste | Début | Fin |
---|---|---|---|
ELANTAS BECK INDIA LIMITED | Compliance Officer | 03/04/2006 | 31/08/2018 |
Responsable des Ressources Humaines | 03/04/2006 | 31/08/2018 | |
Investor Relations Contact | 03/04/2006 | 31/08/2018 | |
Conseiller Juridique Général | 03/04/2006 | 31/08/2018 | |
Secrétaire Général | 03/04/2006 | 31/08/2018 | |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Secrétaire Général | - | - |
Statistiques
Internationale
Inde | 3 |
Opérationnelle
Corporate Secretary | 2 |
Compliance Officer | 1 |
Human Resources Officer | 1 |
Sectorielle
Process Industries | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELANTAS BECK INDIA LIMITED | Process Industries |
Entreprise privées | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Bourse
- Insiders
- Shirish Dabir
- Expérience